8180 related articles for article (PubMed ID: 1659106)
1. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.
Longee DC; Wikstrand CJ; Månsson JE; He X; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD
Acta Neuropathol; 1991; 82(1):45-54. PubMed ID: 1659106
[TBL] [Abstract][Full Text] [Related]
2. GD3 expression by cultured human tumor cells of neuroectodermal origin.
He X; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Acta Neuropathol; 1989; 79(3):317-25. PubMed ID: 2609939
[TBL] [Abstract][Full Text] [Related]
3. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo.
Wikstrand CJ; He XM; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD
J Neuropathol Exp Neurol; 1991 Nov; 50(6):756-69. PubMed ID: 1748882
[TBL] [Abstract][Full Text] [Related]
5. Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens.
Vick WW; Tello JW; Wikstrand CJ; He X; Longee D; Fredman P; Svennerholm L; Bigner DD; Johnston WW; Bigner SH
Acta Cytol; 1992; 36(5):697-705. PubMed ID: 1523927
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to malignant human gliomas.
Wikstrand CJ; Fredman P; Svennerholm L; Humphrey PA; Bigner SH; Bigner DD
Mol Chem Neuropathol; 1992 Oct; 17(2):137-46. PubMed ID: 1384525
[TBL] [Abstract][Full Text] [Related]
7. Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
Wikstrand CJ; Longee DC; McLendon RE; Fuller GN; Friedman HS; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1993 Jan; 53(1):120-6. PubMed ID: 8416736
[TBL] [Abstract][Full Text] [Related]
8. Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.
Wikstrand CJ; Fredman P; Svennerholm L; Bigner DD
Prog Brain Res; 1994; 101():213-23. PubMed ID: 7518092
[TBL] [Abstract][Full Text] [Related]
9. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
Tai T; Kawashima I; Tada N; Dairiki K
J Biochem; 1988 Apr; 103(4):682-7. PubMed ID: 3170507
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.
Saito M; Yu RK; Cheung NK
Biochem Biophys Res Commun; 1985 Feb; 127(1):1-7. PubMed ID: 2579648
[TBL] [Abstract][Full Text] [Related]
11. Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.
Cheung NK; Canete A; Cheung IY; Ye JN; Liu C
Int J Cancer; 1993 May; 54(3):499-505. PubMed ID: 8509225
[TBL] [Abstract][Full Text] [Related]
12. Production of monoclonal antibodies specific for ganglioside GD3.
Watarai S; Onuma M; Yasuda T
J Biochem; 1991 Dec; 110(6):889-95. PubMed ID: 1724444
[TBL] [Abstract][Full Text] [Related]
13. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.
Schulz G; Cheresh DA; Varki NM; Yu A; Staffileno LK; Reisfeld RA
Cancer Res; 1984 Dec; 44(12 Pt 1):5914-20. PubMed ID: 6498849
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside GD2 in reception and transduction of cell death signal in tumor cells.
Doronin II; Vishnyakova PA; Kholodenko IV; Ponomarev ED; Ryazantsev DY; Molotkovskaya IM; Kholodenko RV
BMC Cancer; 2014 Apr; 14():295. PubMed ID: 24773917
[TBL] [Abstract][Full Text] [Related]
16. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
Nishio M; Furukawa K
Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
[TBL] [Abstract][Full Text] [Related]
17. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
Kawashima I; Kotani M; Ozawa H; Suzuki M; Tai T
Int J Cancer; 1994 Jul; 58(2):263-8. PubMed ID: 8026889
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
[TBL] [Abstract][Full Text] [Related]
19. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.
Kawashima I; Tada N; Ikegami S; Nakamura S; Ueda R; Tai T
Int J Cancer; 1988 Feb; 41(2):267-74. PubMed ID: 2448252
[TBL] [Abstract][Full Text] [Related]
20. Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.
Heiss P; Bermatz S; Wehnes H; Heinzmann U; Senekowitsch-Schmidtke R
Anticancer Res; 1997; 17(4B):3145-7. PubMed ID: 9329622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
